Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

OBJECTIVES: Ofatumumab is a human IgG1κ monoclonal antibody that targets a membrane proximal epitope encompassing the small and large loops of CD20. This Phase I study evaluated the safety, tolerability, efficacy and pharmacokinetics of ofatumumab monotherapy in Japanese patients with relapsed/refra...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogura, Michinori, Hatake, Kiyohiko, Tobinai, Kensei, Uchida, Toshiki, Suzuki, Tatsuya, Terui, Yasuhito, Yokoyama, Masahiro, Maruyama, Dai, Mori, Masakazu, Jewell, Roxanne C., Katsura, Koichi, Hotta, Tomomitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638632/
https://www.ncbi.nlm.nih.gov/pubmed/23456745
http://dx.doi.org/10.1093/jjco/hyt022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638632/
https://www.ncbi.nlm.nih.gov/pubmed/23456745
http://dx.doi.org/10.1093/jjco/hyt022

Ejemplares similares